Table of Contents Author Guidelines Submit a Manuscript
International Journal of Surgical Oncology
Volume 2012, Article ID 180259, 9 pages
http://dx.doi.org/10.1155/2012/180259
Review Article

Evaluation of Resection Margins in Breast Conservation Therapy: The Pathology Perspective—Past, Present, and Future

Department of Pathology, University of Illinois Hospital and Health Sciences System, 840 South Wood Street, M/C 847, Chicago, IL 60612, USA

Received 12 August 2012; Revised 16 October 2012; Accepted 22 October 2012

Academic Editor: Joseph P. Crowe

Copyright © 2012 Rajyasree Emmadi and Elizabeth L. Wiley. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. Fisher, S. Anderson, J. Bryant et al., “Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer,” New England Journal of Medicine, vol. 347, no. 16, pp. 1233–1241, 2002. View at Publisher · View at Google Scholar · View at Scopus
  2. U. Veronesi, N. Cascinelli, L. Mariani et al., “Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer,” New England Journal of Medicine, vol. 347, no. 16, pp. 1227–1232, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. J. A. Van Dongen, A. C. Voogd, I. S. Fentiman et al., “Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European organization for research and treatment of cancer 10801 trial,” Journal of the National Cancer Institute, vol. 92, no. 14, pp. 1143–1150, 2000. View at Google Scholar · View at Scopus
  4. P. M. Poortmans, L. Collette, J. C. Horiot et al., “Impact of the boost dose of 10 Gy versus 26 Gy in patients with early stage breast cancer after a microscopically incomplete lumpectomy: 10-year results of the randomised EORTC boost trial,” Radiotherapy and Oncology, vol. 90, no. 1, pp. 80–85, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. S. J. Schnitt, J. L. Connolly, and U. Khettry, “Pathologic findings on re-excision of the primary site in breast cancer patients considered for treatment by primary radiation therapy,” Cancer, vol. 59, no. 4, pp. 675–681, 1987. View at Google Scholar · View at Scopus
  6. N. Rodriguez, L. K. Diaz, and E. L. Wiley, “Predictors of residual disease in repeat excisions for lumpectomies with margins less than 0.1 cm,” Clinical Breast Cancer, vol. 6, no. 2, pp. 169–172, 2005. View at Google Scholar · View at Scopus
  7. N. Kaur, J. Y. Petit, M. Rietjens et al., “Comparative study of surgical margins in oncoplastic surgery and quadrantectomy in breast cancer,” Annals of Surgical Oncology, vol. 12, no. 7, pp. 539–545, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. S. E. Singletary, “Surgical margins in patients with early-stage breast cancer treated with breast conservation therapy,” American Journal of Surgery, vol. 184, no. 5, pp. 383–393, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Skripenova and L. J. Layfield, “Initial margin status for invasive ductal carcinoma of the breast and subsequent identification of carcinoma in reexcision specimens,” Archives of Pathology and Laboratory Medicine, vol. 134, no. 1, pp. 109–114, 2010. View at Google Scholar · View at Scopus
  10. E. L. Wiley, L. K. Diaz, S. Badve, and M. Morrow, “Effect of time interval on residual disease in breast cancer,” American Journal of Surgical Pathology, vol. 27, no. 2, pp. 194–198, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Taghian, M. Mohiuddin, R. Jagsi, S. Goldberg, E. Ceilley, and S. Powell, “Current perceptions regarding surgical margin status after breast-conserving therapy: results of a survey,” Annals of Surgery, vol. 241, no. 4, pp. 629–639, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. R. Holland, S. H. J. Veling, M. Mravunac, and J. H. C. L. Hendriks, “Histologic multifocality of Tis, T1-2 breast carcinomas: implications for clinical trials of breast-conserving surgery,” Cancer, vol. 56, no. 5, pp. 979–990, 1985. View at Google Scholar · View at Scopus
  13. L. J. Solin, I. T. Yeh, J. Kurtz et al., “Ductal carcinoma in situ (intraductal carcinoma) of the breast treated with breast-conserving surgery and definitive irradiation: correlation of pathologic parameters with outcome of treatment,” Cancer, vol. 71, no. 8, pp. 2532–2542, 1993. View at Google Scholar · View at Scopus
  14. K. C. Chan, W. Fiona Knox, G. Sinha et al., “Extent of excision margin width required in breast conserving surgery for ductal carcinoma in situ,” Cancer, vol. 91, no. 1, pp. 9–16, 2001. View at Google Scholar · View at Scopus
  15. M. Dzierzanowski, K. A. Melville, P. J. Barnes, R. F. MacIntosh, J. S. Caines, and G. A. Porter, “Ductal carcinoma in situ in core biopsies containing invasive breast cancer: correlation with extensive intraductal component and lumpectomy margins,” Journal of Surgical Oncology, vol. 90, no. 2, pp. 71–76, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. R. M. Ciocca, T. Li, G. M. Freedman, and M. Morrow, “Presence of lobular carcinoma in situ does not increase local recurrence in patients treated with breast-conserving therapy,” Annals of Surgical Oncology, vol. 15, no. 8, pp. 2263–2271, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Sahoo, W. M. Recant, N. Jaskowiak, L. Tong, and R. Heimann, “Defining negative margins in DCIS patients treated with breast conservation therapy: the University of Chicago experience,” Breast Journal, vol. 11, no. 4, pp. 242–247, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. G. F. Schwartz, A. S. Patchefsky, S. D. Finklestein et al., “Nonpalpable in situ ductal carcinoma of the breast. Predictors of multicentricity and microinvasion and implications for treatment,” Archives of Surgery, vol. 124, no. 1, pp. 29–32, 1989. View at Google Scholar · View at Scopus
  19. A. B. Chagpar, R. C. G. Martin, L. J. Hagendoorn, C. Chao, and K. M. McMasters, “Lumpectomy margins are affected by tumor size and histologic subtype but not by biopsy technique,” American Journal of Surgery, vol. 188, no. 4, pp. 399–402, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. D. L. Page, M. D. Lagios, E. R. Fisher et al., “Pathologic analysis of the National Surgical Adjuvant Breast Project (NSABP) B-17 trial: unanswered questions remaining unanswered considering current concepts of ductal carcinoma in situ,” Cancer, vol. 75, no. 6, pp. 1219–1227, 1995. View at Publisher · View at Google Scholar · View at Scopus
  21. D. R. Holmes, W. Schooler, and R. Smith, “Oncoplastic approaches to breast conservation,” International Journal of Breast Cancer, vol. 2011, Article ID 303879, 16 pages, 2011. View at Publisher · View at Google Scholar
  22. J. A. Guidroz, G. Larrieux, J. Liao, S. L. Sugg, C. E. H. Scott-Conner, and R. J. Weigel, “Sampling of secondary margins decreases the need for re-excision after partial mastectomy,” Surgery, vol. 150, no. 4, pp. 802–809, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Kobbermann, A. Unzeitig, X. J. Xie et al., “Impact of routine cavity shave margins on breast cancer re-excision rates,” Annals of Surgical Oncology, vol. 18, no. 5, pp. 1349–1355, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Muttalib, M. Tisdall, R. Scawn, S. Shousha, R. S. Cummins, and H. D. Sinnett, “Intra-operative specimen analysis using faxitron microradiography for excision of mammographically suspicious, non-palpable breast lesions,” Breast, vol. 13, no. 4, pp. 307–315, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. L. Bathla, A. Harris, M. Davey, P. Sharma, and E. Silva, “High resolution intra-operative two-dimensional specimen mammography and its impact on second operation for re-excision of positive margins at final pathology after breast conservation surgery,” American Journal of Surgery, vol. 202, no. 4, pp. 387–394, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. R. Schulz-Wendtland, M. R. Bani, M. P. Lux et al., “CMOS technology for intraoperative digital imaging: can the re-excision rate after breast surgery be reduced?” Geburtshilfe und Frauenheilkunde, vol. 71, no. 6, pp. 525–529, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. V. S. Klimberg, K. C. Westbrook, and S. Korourian, “Use of touch preps for diagnosis and evaluation of surgical margins in breast cancer,” Annals of Surgical Oncology, vol. 5, no. 3, pp. 220–226, 1998. View at Publisher · View at Google Scholar · View at Scopus
  28. E. K. Valdes, S. K. Boolbol, J. M. Cohen, and S. M. Feldman, “Intra-operative touch preparation cytology; does it have a role in re-excision lumpectomy?” Annals of Surgical Oncology, vol. 14, no. 3, pp. 1045–1050, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. J. B. Osborn, G. L. Keeney, J. W. Jakub, A. C. Degnim, and J. C. Boughey, “Cost-effectiveness analysis of routine frozen-section analysis of breast margins compared with reoperation for positive margins,” Annals of Surgical Oncology, vol. 18, no. 11, pp. 3204–3209, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. J. C. Cendán, D. Coco, and E. M. Copeland, “Accuracy of intraoperative frozen-section analysis of breast cancer lumpectomy-bed margins,” Journal of the American College of Surgeons, vol. 201, no. 2, pp. 194–198, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. J. A. Margenthaler, F. Gao, and V. S. Klimberg, “Margin index: a new method for prediction of residual disease after breast-conserving surgery,” Annals of Surgical Oncology, vol. 17, no. 10, pp. 2696–2701, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. M. Morrow, J. R. Harris, and S. J. Schnitt, “Surgical margins in lumpectomy for breast cancer—bigger is not better,” New England Journal of Medicine, vol. 367, no. 1, pp. 79–82, 2012. View at Publisher · View at Google Scholar · View at Scopus